Financials data is unavailable for this security.
View more
Year on year Sotac Pharmaceuticals Ltd had revenues fall -20.74% from 731.52m to 579.83m, though the company grew net income 56.17% from 28.79m to 44.96m.
Gross margin | 30.90% |
---|---|
Net profit margin | 7.75% |
Operating margin | 11.35% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2023, Sotac Pharmaceuticals Ltd increased its cash reserves by 34,676.81%, or 95.71m. Cash Flow from Financing totalled 119.65m or 20.64% of revenues. In addition the company generated 85.36m in cash from operations while cash used for investing totalled 109.31m.
Cash flow per share | 6.41 |
---|---|
Price/Cash flow per share | 27.08 |
Book value per share | 14.31 |
---|---|
Tangible book value per share | 14.31 |
More ▼
Balance sheet in INRView more
Current ratio | 1.35 |
---|---|
Quick ratio | 0.9968 |
Total debt/total equity | 0.9252 |
---|---|
Total debt/total capital | 0.4806 |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 114.20%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -- |